Literature DB >> 8459210

B lymphocytes may escape tolerance by revising their antigen receptors.

M Z Radic1, J Erikson, S Litwin, M Weigert.   

Abstract

To explore mechanisms that prevent autoreactivity in nonautoimmune mice, endogenous immunoglobulin (Ig) light (L) chains that associate with a transgenic anti-DNA heavy chain were analyzed. The antibodies from splenic B cell hybridomas of such mice did not bind double-stranded DNA (dsDNA) and their L chain sequences showed a biased use of V kappa and J kappa gene segments. The 44 L chains in this survey were coded for by just 18 germline genes. Six of the genes, each belonging to a different V kappa group, were used more than once and accounted for three fourths of all sequences. Based on the distribution of V kappa genes, the L chain repertoire in this line of transgenic mice was estimated at 37 V kappa genes. The most frequently observed gene, a member of the V kappa 12/13 group, was identified in 16 hybrids. In addition, the majority of V kappa genes used J kappa 5. We interpret the skewed representation of V kappa and J kappa gene segments to result from negative selection. Based on the data, we suggest that V kappa rearrangements giving rise to anti-dsDNA reactivity are removed from the repertoire by a corrective mechanism capable of editing self-reactive Ig.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8459210      PMCID: PMC2190988          DOI: 10.1084/jem.177.4.1165

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  Double recombination of a single immunoglobulin kappa-chain allele: implications for the mechanism of rearrangement.

Authors:  R M Feddersen; B G Van Ness
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

2.  Rearrangement of immunoglobulin heavy chain genes during B-lymphocyte development as revealed by studies of mouse plasmacytoma cells.

Authors:  C Coleclough; D Cooper; R P Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

3.  Novel kappa light-chain gene rearrangements in mouse lambda light chain-producing B lymphocytes.

Authors:  J Durdik; M W Moore; E Selsing
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

4.  Ongoing V kappa-J kappa recombination after formation of a productive V kappa-J kappa coding joint.

Authors:  C Huber; H G Klobeck; H G Zachau
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

5.  Different joining region J elements of the murine kappa immunoglobulin light chain locus are used at markedly different frequencies.

Authors:  D L Wood; C Coleclough
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Inhibition of abnormal T cell development and autoimmunity in gld mice by transgenic T cell receptor beta chain.

Authors:  K Yui; A Bhandoola; M Z Radic; S Komori; M Katsumata; M I Greene
Journal:  Eur J Immunol       Date:  1992-07       Impact factor: 5.532

7.  Preferential rearrangement of the immunoglobulin kappa chain joining region J kappa 1 and J kappa 2 segments in mouse spleen DNA.

Authors:  M Nishi; T Kataoka; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  5' flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains.

Authors:  K B Marcu; J Banerji; N A Penncavage; R Lang; N Arnheim
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

9.  Most peripheral B cells in mice are ligand selected.

Authors:  H Gu; D Tarlinton; W Müller; K Rajewsky; I Förster
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

10.  Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice.

Authors:  D M Tillman; N T Jou; R J Hill; T N Marion
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  133 in total

1.  Concanavalin A stimulation enhanced secondary VlambdaJlambda rearrangement in some human plasma B cells without up-regulation of recombination-activating gene expression and Vlambda germline transcription.

Authors:  H Haruta; H Tachibana; K Yamada
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

2.  B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection.

Authors:  V Kouskoff; G Lacaud; K Pape; M Retter; D Nemazee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 3.  Role of B cell antigen receptor in regulation of V(D)J recombination and cell survival.

Authors:  D Nemazee
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 4.  Relative roles of somatic and Darwinian evolution in shaping the antibody response.

Authors:  M Diaz; N R Klinman
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 5.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

6.  B cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition.

Authors:  J Lang; D Nemazee
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

Review 7.  Double light chain producing lymphocytes: an enigma of allelic exclusion.

Authors:  L Diaw; D Siwarski; K Huppi
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

8.  Receptor revision of immunoglobulin heavy chain genes in human MALT lymphomas.

Authors:  D Lenze; A Greiner; C Knörr; I Anagnostopoulos; H Stein; M Hummel
Journal:  Mol Pathol       Date:  2003-10

9.  Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion.

Authors:  Yasushi Miura; Charles C Chu; David M Dines; Stanley E Asnis; Richard A Furie; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

Review 10.  Regulation of the antibody repertoire through control of HCDR3 diversity.

Authors:  H W Schroeder; G C Ippolito; S Shiokawa
Journal:  Vaccine       Date:  1998 Aug-Sep       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.